Skip to main content
Clinical Trials/NCT06588933
NCT06588933
Recruiting
Not Applicable

The Development and Validation of a Novel Tool for the Assessment of Taste Disturbances in Patients With Advanced Cancer: Taste Questionnaire in Palliative Care

Prof Andrew Davies1 site in 1 country200 target enrollmentSeptember 1, 2023
ConditionsAltered Taste

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Altered Taste
Sponsor
Prof Andrew Davies
Enrollment
200
Locations
1
Primary Endpoint
To develop a novel assessment tool to assess taste disturbances in patients with advanced cancer
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Taste problems are common among patients with advanced cancer. These symptoms can affect the pleasure of eating and drinking, reduce dietary intake, cause low mood, and a lower quality of life. There is no validated tool to assess taste disturbances and their impact on patients with advanced cancer. This study will develop and validate a novel assessment tool to assess taste disturbances and their impact on patients with advanced cancer.

Detailed Description

Patients with advanced cancer often develop taste disturbances. A recent literature review reported a median prevalence of 55%, with prevalence ranging from 27-93%. Studies have shown taste disturbance is usually a persistent symptom, is often 'moderate-to-severe' in intensity, and is often associated with significant distress. Taste disturbance may have a major impact on the experience and pleasure associated with eating and drinking. Taste disturbance may have a major impact on nutritional intake. It may be associated with low mood / depression, social isolation, and an impaired quality of life. The aforementioned literature review identified, importantly, that the terminology used in the published literature varied, which may have had an effect on the results obtained, especially prevalence statistics. The review identified the need for "development/validation studies of a taste-specific assessment tool for this group of patients - there is a need for a tool that not only assesses the problem but can also assess the response to treatment for the problem, utilising patient reported outcome measures."

Registry
clinicaltrials.gov
Start Date
September 1, 2023
End Date
December 31, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Prof Andrew Davies
Responsible Party
Sponsor Investigator
Principal Investigator

Prof Andrew Davies

Professor of Palliative Medicine

Our Lady's Hospice and Care Services

Eligibility Criteria

Inclusion Criteria

  • 18 years of age Diagnosis of locally advanced or metastatic cancer Referred to palliative care/oncology services Taste problems rated 'moderate' or worse over previous 2-week period Good understanding of English

Exclusion Criteria

  • Cognitive impairment (unable to provide consent / complete questionnaire) Taste problems precedes cancer diagnosis. Head and neck surgery Head and neck radiotherapy Salivary gland disorders (e.g., Sjogren's Syndrome) In the 'Deteriorating' or 'Terminal' Phase of illness

Outcomes

Primary Outcomes

To develop a novel assessment tool to assess taste disturbances in patients with advanced cancer

Time Frame: December 2025

To develop the Taste Questionnaire in Palliative Care (TQ-PAL) to assess taste disturbances and their impact on patients with palliative care. It's domains include the effect on food intake, social inclusion, and quality of life

To validate the newly developed Taste Questionnaire in Palliative Care (TQ-PAL)

Time Frame: December 2025

To test the TQ-PAL for face, content, construct, convergent and reliability validation.

Study Sites (1)

Loading locations...

Similar Trials